NCT03761797View on ClinicalTrials.gov

A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

1,164

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

March 10, 2021

Study Completion Date

April 27, 2021

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

TRADIANCE® Combination Tablets AP

Fixed dose combination

DRUG

TRADIANCE® Combination Tablets BP

Fixed dose combination

Trial Locations (1)

1416017

Nippon Boehringer Ingelheim Co., Ltd, Tokyo

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY

NCT03761797 - A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter